US SB1250 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 20 2023 - 25% progression
Action: 2023-04-20 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 20 2023 - 25% progression
Action: 2023-04-20 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Title
Drug-price Transparency for Consumers Act of 2023
Sponsors
| Sen. Richard Durbin [D-IL] | Sen. Chuck Grassley [R-IA] | Sen. Angus King [I-ME] | Sen. Mike Braun [R-IN] |
| Sen. Richard Blumenthal [D-CT] | Sen. J.D. Vance [R-OH] | Sen. Tammy Baldwin [D-WI] | Sen. Sherrod Brown [D-OH] |
| Sen. Tina Smith [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-20 | Senate | Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298) |
Same As/Similar To
HB5958 (Same As) 2023-10-25 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1250/all-info |
| Text | https://www.congress.gov/118/bills/s1250/BILLS-118s1250is.pdf |
